IN23: Experimental IN23:
Experimental urology is a group dedicated to research in uro-oncology and the investigation of new techniques and innovation. Our main line of research is uro-oncology and immunotherapy, as well as various uro-oncological treatments. These are the cutting-edge areas of urology.
Responsible researcher
- José Luis Álvarez-Ossorio Fernández:
- E-mail: urossorio@gmail.com
- ORCID: 0000-0001-9956-8453
Co-principal investigator
- Jesus Maria Rosety Rodriguez:
- E-mail: jeroro@icloud.com
- ORCID: 0000-0001-8787-9721
Lines of research
- Line 1: Metastatic renal cancer.
- Line 2: Bladder cancer. Molecular markers.
- Line 3: Prostate cancer. Liquid biopsy.
- Line 4: Fertility and sports.
Keywords
- # Cancer
- # Kidney
- # Bladder
- # Andrology
- # Bioquímica
IN23: Experimental IN23:
Responsible researcher
José Luis Álvarez-Ossorio Fernández:
Head of Urology Department, Puerta del Mar Hospital.
- E-mail: urossorio@gmail.com
- ORCID: 0000-0001-9956-8453
- Scopus ID: 6603195757
Co-principal investigator
Jesús María Rosety Rodríguez:
FEA UROLOGY Puerta del Mar Hospital (Resident Tutor).
- E-mail: jeroro@icloud.com
- ORCID: 0000-0001-8787-9721
- Research ID: Q-1360-2017
- Scopus ID: 6506071903
Team Members
- Principal Investigators:
- José Luis Álvarez-Ossorio Fernández (PI).
- Jesús María Rosety Rodríguez (Co-IR).
- Researchers:
- Blanca Madurga Patuel.
- Cristina León Delgado.
- María José Ledo Cepero.
- Rodrigo García-Baquero García de Paredes.
- Ana Victoria Ojeda, of course.
- Cristina Salvatierra Perez.
- Manuel Soto Delgado.